ÂÜÀòÂÒÂ×

Seth Bilazarian, MD, currently serves as an Observer on the Board of Directors at Third Pole Therapeutics since December 2022 and has held various senior positions at Abiomed since October 2015, including Senior Vice President, Vice President, Chief Medical Officer, and Vice President of Interventional Cardiology. In addition, Seth Bilazarian contributes as a Scientific Advisory Board Member at BraveHeart Wireless, Inc. and has extensive experience as a Clinical and Interventional Cardiologist at Pentucket Medical Associates from July 1993 to October 2015, as well as at Lahey Clinic during the same period. Educational credentials include a Doctor of Medicine from UMass Chan Medical School, a fellowship in Clinical and Interventional Cardiology from Boston University School of Medicine, and a graduate medical residency from The Johns Hopkins University School of Medicine. Seth Bilazarian also has a Bachelor of Science in Chemical Engineering from Tufts University.